Greg Shertzer, PharmD, is an accomplished professional with extensive experience in investor relations and medical science liaison roles. Currently serving as Director of Investor Relations at Incyte since May 2021, Greg previously held positions at Rigel Pharmaceuticals Inc. as Senior Medical Science Liaison and at The Medical Affairs Company as a Medical Science Liaison. Greg's background includes a fellowship at Bristol-Myers Squibb, where responsibilities spanned medical information, clinical trials operations, and medical science liaison activities focused on oncology products. Early career experience includes internships and technician roles at Penn State Health Milton S. Hershey Medical Center and Lock Haven Hospital. Educational qualifications include a Doctor of Pharmacy degree from Temple University, supplemented by studies in global clinical and pharmacovigilance regulations, as well as a Bachelor of Science in Cellular and Molecular Biology from Commonwealth University-Lock Haven.
This person is not in any teams
This person is not in any offices